These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8125216)

  • 1. Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats.
    Wolfgang GH; Dominick MA; Walsh KM; Hoeschele JD; Pegg DG
    Fundam Appl Toxicol; 1994 Jan; 22(1):73-9. PubMed ID: 8125216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative nephrotoxicity of carboplatin and cisplatin in euvolemic and dehydrated rats.
    Martinez F; Deray G; Dubois M; Beaufils H; Jacquiaud C; Bourbouze R; Benhmida M; Jaudon MC; Jacobs C
    Anticancer Drugs; 1993 Feb; 4(1):85-90. PubMed ID: 8457719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.
    Yasumasu T; Ueda T; Uozumi J; Mihara Y; Kumazawa J
    Pharmacol Toxicol; 1992 Feb; 70(2):143-7. PubMed ID: 1508841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents.
    McKeage MJ; Morgan SE; Boxall FE; Murrer BA; Hard GC; Harrap KR
    Br J Cancer; 1993 May; 67(5):996-1000. PubMed ID: 8494733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential toxicity of cisplatin, carboplatin, and CI-973 correlates with cellular platinum levels in rat renal cortical slices.
    Leibbrandt ME; Wolfgang GH
    Toxicol Appl Pharmacol; 1995 Jun; 132(2):245-52. PubMed ID: 7785052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
    Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
    Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of verapamil on cis-platinum and carboplatinum nephrotoxicity in dehydrated and normohydrated rats.
    Haragsim L; Zima T
    Biochem Int; 1992 Oct; 28(2):273-6. PubMed ID: 1360799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue injury and repair in the rat kidney after exposure to cisplatin or carboplatin.
    Nonclercq D; Toubeau G; Laurent G; Tulkens PM; Heuson-Stiennon JA
    Exp Mol Pathol; 1989 Oct; 51(2):123-40. PubMed ID: 2680578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system.
    Stöhr W; Paulides M; Bielack S; Jürgens H; Koscielniak E; Rossi R; Langer T; Beck JD
    Pediatr Blood Cancer; 2007 Feb; 48(2):140-7. PubMed ID: 16724313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
    Hanada K; Asano K; Nishimura T; Chimata T; Matsuo Y; Tsuchiya M; Ogata H
    J Pharm Pharmacol; 2008 Mar; 60(3):317-22. PubMed ID: 18284811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin.
    Bregman CL; Williams PD
    Cancer Chemother Pharmacol; 1986; 18(2):117-23. PubMed ID: 3539384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renal fractional clearance of platinum antitumour compounds in relation to nephrotoxicity.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1985 May; 34(9):1423-8. PubMed ID: 4039567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal responses to atrial natriuretic peptide (ANP) in rats with non-oliguric acute renal failure induced by cisplatin.
    Nagano N; Yagi M; Kato S; Furuya Y; Miyata S; Manabe N
    J Vet Med Sci; 1995 Dec; 57(6):997-1002. PubMed ID: 8720036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
    Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental studies on the pharmacokinetics and nephrotoxicity of carboplatin (cis-diammine-1, 1-cyclobutane dicarboxylate platinum II) in rats.
    Ueda T; Yasumasu T; Uozumi J
    J Toxicol Sci; 1991 Aug; 16(3):101-9. PubMed ID: 1942134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo biochemical indices of nephrotoxicity of platinum analogs tetraplatin, CHIP, and cisplatin in the Fischer 344 rat.
    Smith MA; Smith JH; Litterst CL; Copley MP; Uozumi J; Boyd MR
    Fundam Appl Toxicol; 1988 Jan; 10(1):62-72. PubMed ID: 3350230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats.
    Mohan IK; Khan M; Shobha JC; Naidu MU; Prayag A; Kuppusamy P; Kutala VK
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):802-8. PubMed ID: 16552571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells.
    Leibbrandt ME; Wolfgang GH; Metz AL; Ozobia AA; Haskins JR
    Kidney Int; 1995 Sep; 48(3):761-70. PubMed ID: 7474662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural alterations and DNA synthesis of renal cell nuclei following cisplatin or carboplatin injection in rats.
    Yasumasu T; Ueda T; Uozumi J; Mihara Y; Koikawa Y; Kumazawa J
    J Pharm Pharmacol; 1992 Nov; 44(11):885-7. PubMed ID: 1361530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.